Adherence to Medications: Insights Arising from Studies on the Unreliable Link Between Prescribed and Actual Drug Dosing Histories
被引:301
作者:
Blaschke, Terrence F.
论文数: 0引用数: 0
h-index: 0
机构:
Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA
Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USAStanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA
Blaschke, Terrence F.
[1
,2
]
Osterberg, Lars
论文数: 0引用数: 0
h-index: 0
机构:
Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA
Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USAStanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA
机构:
Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA
AARDEX Grp Ltd, CH-1950 Sion, SwitzerlandStanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA
Urquhart, John
[2
,4
]
机构:
[1] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA
[2] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA
[3] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA
Satisfactory adherence to aptly prescribed medications is essential for good outcomes of patient care and reliable evaluation of competing modes of drug treatment. The measure of satisfactory adherence is a dosing history that includes timely initiation of dosing plus punctual and persistent execution of the dosing regimen throughout the specified duration of treatment. Standardized terminology for initiation, execution, and persistence of drug dosing is essential for clarity of communication and scientific progress. Electronic methods for compiling drug dosing histories are now the recognized standard for quantifying adherence, the parameters of which support model-based, continuous projections of drug actions and concentrations in plasma that are confirmable by intermittent, direct measurements at single time points. The frequency of inadequate adherence is usually underestimated by pre-electronic methods and thus is clinically unrecognized as a frequent cause of failed treatment or underestimated effectiveness. Intermittent lapses in dosing are potential sources of toxicity through hazardous rebound effects or recurrent first-dose effects.
机构:
Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94143 USAUniv Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94143 USA
Bangsberg, DR
Perry, S
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94143 USA
Perry, S
Charlebois, ED
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94143 USA
Charlebois, ED
Clark, RA
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94143 USA
Clark, RA
Roberston, M
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94143 USA
Roberston, M
Zolopa, AR
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94143 USA
Zolopa, AR
Moss, A
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94143 USA
机构:
Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94143 USAUniv Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94143 USA
Bangsberg, DR
Perry, S
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94143 USA
Perry, S
Charlebois, ED
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94143 USA
Charlebois, ED
Clark, RA
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94143 USA
Clark, RA
Roberston, M
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94143 USA
Roberston, M
Zolopa, AR
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94143 USA
Zolopa, AR
Moss, A
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94143 USA